| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Clinical Chemistry, Vol 32, 778-781, Copyright © 1986 by American Association for Clinical Chemistry
HJ Lenzen, G Assmann, R Buchwalsky and H Schulte
We determined the frequencies of genetic apolipoprotein E isoforms in 570 survivors of myocardial infarction, all with demonstrable coronary heart disease, as compared with 624 healthy persons. In controls, E-4/E- 3 heterozygosity was associated with total cholesterol concentrations of 1985 (SD 364) mg/L and low-density lipoprotein (LDL)-cholesterol concentrations of 1306 (SD 332) mg/L. Significantly lower values, 1811 (SD 312) mg/L and 1121 (SD 274) mg/L, respectively, were observed for E- 3/E-2 heterozygous persons. In survivors of myocardial infarction, the respective values were significantly higher than in controls, differing between E-4/E-3 and E-3/E-2 heterozygous patients by 233 and 220 mg/L, respectively. Moreover, E-4/E-3 heterozygosity was accompanied by earlier age of myocardial infarction (48.8 +/- 7.4 years) as compared with E-3/E-2 heterozygosity (53.4 +/- 6.9 years) and E-3/E-3 homozygosity (51.2 +/- 7.7 years). Evidently, apolipoprotein E polymorphism can contribute to total and LDL-cholesterol concentrations in serum, thereby affecting risk of coronary heart disease and myocardial infarction.
The following articles in journals at HighWire Press have cited this article:
|
|
 |
|
  A. M. Bennet, E. Di Angelantonio, Z. Ye, F. Wensley, A. Dahlin, A. Ahlbom, B. Keavney, R. Collins, B. Wiman, U. de Faire, et al. Association of Apolipoprotein E Genotypes With Lipid Levels and Coronary Risk JAMA, September 19, 2007; 298(11): 1300 - 1311. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Rej Clinical Chemistry through Clinical Chemistry: A Journal Timeline Clin. Chem., December 1, 2004; 50(12): 2415 - 2458. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Song, M. J. Stampfer, and S. Liu Meta-Analysis: Apolipoprotein E Genotypes and Risk for Coronary Heart Disease Ann Intern Med, July 20, 2004; 141(2): 137 - 147. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Grunenfelder, M. Umbehr, A. Plass, L. Bestmann, F. E. Maly, G. Zund, and M. Turina Genetic polymorphisms of apolipoprotein E4 and tumor necrosis factor {beta} as predisposing factors for increased inflammatory cytokines after cardiopulmonary bypass J. Thorac. Cardiovasc. Surg., July 1, 2004; 128(1): 92 - 97. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Lehtimaki, P. Dastidar, H. Jokela, T. Koivula, S. Lehtinen, C. Ehnholm, and R. Punnonen Effect of Long-Term Hormone Replacement Therapy on Atherosclerosis Progression in Postmenopausal Women Relates to Functional Apolipoprotein E Genotype J. Clin. Endocrinol. Metab., September 1, 2002; 87(9): 4147 - 4153. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E. Eichner, S. T. Dunn, G. Perveen, D. M. Thompson, K. E. Stewart, and B. C. Stroehla Apolipoprotein E Polymorphism and Cardiovascular Disease: A HuGE Review Am. J. Epidemiol., March 15, 2002; 155(6): 487 - 495. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. F. Newman, D. T. Laskowitz, W. D. White, J. L. Kirchner, H. P. Grocott, M. Stafford-Smith, M. H. Sketch, R. H. Jones, J. G. Reves, and A. M. Saunders Apolipoprotein E Polymorphisms and Age at First Coronary Artery Bypass Graft Anesth. Analg., April 1, 2001; 92(4): 824 - 829. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Isbir, B. Agachan, H. Yilmaz, M. Aydin, I. Kara, E. Eker, and D. Eker Apolopoprotein-E gene polymorphism and lipid profiles in Alzheimer's disease American Journal of Alzheimer's Disease and Other Dementias, March 1, 2001; 16(2): 77 - 81. [Abstract] [PDF]
|
|
|
|
 |
|
 C. D. McCullagh, D. Craig, S. P. McIlroy, and A. P. Passmore Risk factors for dementia Advan. Psychiatr. Treat., January 1, 2001; 7(1): 24 - 31. [Full Text]
|
|
|
|
|
|
A. Batalla, R. Alvarez, J. R. Reguero, S. Hevia, G. Iglesias-Cubero, V. Alvarez, A. Cortina, P. Gonzalez, M. M. Celada, A. Medina, et al. Synergistic Effect between Apolipoprotein E and Angiotensinogen Gene Polymorphisms in the Risk for Early Myocardial Infarction Clin. Chem., December 1, 2000; 46(12): 1910 - 1915. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. R. Isasi, S. Shea, R. J. Deckelbaum, S. C. Couch, T. J. Starc, J. D. Otvos, and L. Berglund Apolipoprotein epsilon 2 Allele Is Associated With an Anti-atherogenic Lipoprotein Profile in Children: The Columbia University BioMarkers Study Pediatrics, September 1, 2000; 106(3): 568 - 575. [Abstract] [Full Text]
|
|
|
|
 |
|
 C. DeCarli, T. Reed, B. L. Miller, P. A. Wolf, G. E. Swan, and D. Carmelli Impact of Apolipoprotein E {epsilon}4 and Vascular Disease on Brain Morphology in Men From the NHLBI Twin Study Stroke, August 1, 1999; 30(8): 1548 - 1553. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. L. R. Kardia, M. B. Haviland, R. E. Ferrell, and C. F. Sing The Relationship Between Risk Factor Levels and Presence of Coronary Artery Calcification is Dependent on Apolipoprotein E Genotype Arterioscler. Thromb. Vasc. Biol., February 1, 1999; 19(2): 427 - 435. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. B Frisoni, M. Manfredi, C. Geroldi, G. Binetti, O. Zanetti, A. Bianchetti, and M. Trabucchi The prevalence of apoE-epsilon 4 in Alzheimer's disease is age dependent J. Neurol. Neurosurg. Psychiatry, July 1, 1998; 65(1): 103 - 106. [Abstract] [Full Text]
|
|
|
|
|
|
A. Pablos-Mendez, R. Mayeux, C. Ngai, S. Shea, and L. Berglund Association of Apo E Polymorphism With Plasma Lipid Levels in a Multiethnic Elderly Population Arterioscler. Thromb. Vasc. Biol., December 1, 1997; 17(12): 3534 - 3541. [Abstract] [Full Text]
|
|
|
|
|
|
I. Raiha, J. Marniemi, P. Puukka, T. Toikka, C. Ehnholm, and L. Sourander Effect of Serum Lipids, Lipoproteins, and Apolipoproteins on Vascular and Nonvascular Mortality in the Elderly Arterioscler. Thromb. Vasc. Biol., July 1, 1997; 17(7): 1224 - 1232. [Abstract] [Full Text]
|
|
|
|
|
|
P. W.F. Wilson, E. J. Schaefer, M. G. Larson, and J. M. Ordovas Apolipoprotein E Alleles and Risk of Coronary Disease: A Meta-analysis Arterioscler. Thromb. Vasc. Biol., October 1, 1996; 16(10): 1250 - 1255. [Abstract] [Full Text]
|
|
|
|
|
|
J. Kuusisto, L. Mykkanen, K. Kervinen, Y. A. Kesaniemi, and M. Laakso Apolipoprotein E4 Phenotype Is Not an Important Risk Factor for Coronary Heart Disease or Stroke in Elderly Subjects Arterioscler. Thromb. Vasc. Biol., September 1, 1995; 15(9): 1280 - 1286. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. H. Stengard, K. E. Zerba, J. Pekkanen, C. Ehnholm, A. Nissinen, and C. F. Sing Apolipoprotein E Polymorphism Predicts Death From Coronary Heart Disease in a Longitudinal Study of Elderly Finnish Men Circulation, January 15, 1995; 91(2): 265 - 269. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
